New Parkinson's pill aims to cut down 'off' episodes
NCT ID NCT06596876
First seen Jun 09, 2026 · Last updated Jun 12, 2026 · Updated 3 times
Summary
This study tested a new medication called HRG2010 in 165 people with Parkinson's disease who experience motor fluctuations — times when their symptoms return between doses. The goal was to see if HRG2010 could reduce daily 'off' time better than a standard extended-release carbidopa-levodopa. Participants took either the new drug or the standard one for 21 weeks, and researchers measured changes in symptom control and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, 100730, China
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.